Author name: Innoglide Pharma

The Indian Pharmaceutical Alliance (IPA) has raised concerns regarding the interpretation of data from the US Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS) in a recent study by Ohio State University titled “Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events.” IPA […]

Entrepreneurs often find themselves caught between the relentless demands of their ventures and the essential need for restorative sleep. This struggle is not uncommon; a recent survey revealed that 55% of startup founders and business leaders grapple with sleep issues due to demanding work hours and high-stakes decision-making. If you are an entrepreneur looking to improve

Recent research has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a significant biomarker for predicting the progression of Type 1 Diabetes (T1D). This discovery holds potential for developing effective intervention strategies to manage and possibly prevent the onset of T1D in at-risk individuals. The Future of T1D Management relies on such groundbreaking insights to

Glenmark Therapeutics Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Polyethylene Glycol 3350, Powder for Solution, 17 grams per capful, available over-the-counter (OTC). This product is comparable to the active ingredient found in MiraLAX® Powder for Solution, 17 grams, by Bayer HealthCare LLC. Glenmark Launches OTC Polyethylene Glycol 3350 Powder

AstraZeneca has secured approval from the Central Drugs Standard Control Organisation (CDSCO) to import Sodium Zirconium Cyclosilicate (SZC) for the treatment of hyperkalaemia in adult patients. This development is poised to enhance the management of hyperkalaemia, a condition characterized by elevated potassium levels in the blood, which can lead to serious health complications if left

The recent Belgian Economic Mission to India has underscored the growing India-Belgium Collaborations in the life sciences sector, highlighting a shared commitment to advancing healthcare innovations and addressing global health challenges.   Strengthening Bilateral Ties in Life Sciences The mission facilitated a series of seminars and discussions, bringing together leaders, researchers, and stakeholders from both

Women have been making significant strides in Science, Technology, Engineering, and Mathematics (STEM), breaking barriers and leading innovations across various sectors. Their contributions are not only reshaping industries but also inspiring future generations to pursue careers in these fields. Women Leaders in STEM are setting new benchmarks, proving that diversity in science and technology leads

Senores Pharmaceuticals Limited (SPL), an Ahmedabad-based pharmaceutical company, has made a significant move in the U.S. generics market by acquiring 14 Abbreviated New Drug Applications (ANDAs) from Dr. Reddy’s Laboratories and its affiliates. This strategic acquisition by Senores Pharma includes 13 approved ANDAs by the U.S. Food and Drug Administration (USFDA) and one pending approval,

VeGen Labs LLP, a pioneering biotechnology startup incubated at the University of Hyderabad’s ASPIRE-TBI and ASPIRE-BioNEST, has secured ₹3.765 crore in funding from the Biotechnology Industry Research Assistance Council (BIRAC), a government-backed initiative supporting biotech innovation in India. This funding will be used to advance Investigational New Drug (IND)-enabling toxicology studies for IND126, a novel

Amoxicillin–Clavulanic Acid, commonly known by the brand name Augmentin, is a widely used antibiotic combination effective against various bacterial infections. This combination pairs amoxicillin, a β-lactam antibiotic, with clavulanic acid, a β-lactamase inhibitor, to overcome bacterial resistance mechanisms. Mechanism of Action Amoxicillin targets and inhibits penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting